---
title: "12 Health Care Stocks Moving In Wednesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290085511.md"
description: "During Wednesday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Icecure Medical (up 290.6%), uniQure (up 74.84%), and Lunai Bioworks (up 57.99%). Conversely, major losers featured Aditxt (down 42.2%), Regentis Biomaterials (down 20.01%), and Spero Therapeutics (down 18.24%). The report highlights substantial price movements across various market capitalizations in the healthcare sector."
datetime: "2026-06-17T17:06:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290085511.md)
  - [en](https://longbridge.com/en/news/290085511.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290085511.md)
---

# 12 Health Care Stocks Moving In Wednesday's Intraday Session

### Gainers

-   **Icecure Medical** (NASDAQ:ICCM) stock increased by 290.6% to $8.32 during Wednesday's regular session. The company's market cap stands at $179.3 million.
-   **uniQure** (NASDAQ:QURE) shares moved upwards by 74.84% to $47.19. The market value of their outstanding shares is at $1.7 billion.
-   **Lunai Bioworks** (NASDAQ:LNAI) shares rose 57.99% to $4.5. The market value of their outstanding shares is at $12.8 million.
-   **Elicio Therapeutics** (NASDAQ:ELTX) stock moved upwards by 42.18% to $3.92. The company's market cap stands at $52.6 million.
-   **ClearPoint Neuro** (NASDAQ:CLPT) stock rose 33.43% to $17.8. The market value of their outstanding shares is at $400.0 million.
-   **Stablecoin Development** (AMEX:SDEV) stock increased by 25.21% to $1.39. The company's market cap stands at $30.0 million.

### Losers

-   **Aditxt** (NASDAQ:ADTX) stock declined by 42.2% to $0.01 during Wednesday's regular session.
-   **Regentis Biomaterials** (AMEX:RGNT) stock declined by 20.01% to $4.88. The company's market cap stands at $31.5 million.
-   **Spero Therapeutics** (NASDAQ:SPRO) stock fell 18.24% to $2.27. The company's market cap stands at $160.3 million.
-   **Co-Diagnostics** (NASDAQ:CODX) shares fell 17.32% to $3.17. The company's market cap stands at $14.1 million.
-   **CervoMed** (NASDAQ:CRVO) stock decreased by 15.49% to $3.82. The company's market cap stands at $41.8 million.
-   **IM Cannabis** (NASDAQ:IMCC) stock declined by 14.74% to $0.22. The company's market cap stands at $2.3 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [QURE.US](https://longbridge.com/en/quote/QURE.US.md)
- [RGNT.US](https://longbridge.com/en/quote/RGNT.US.md)
- [ICCM.US](https://longbridge.com/en/quote/ICCM.US.md)
- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [SPRO.US](https://longbridge.com/en/quote/SPRO.US.md)
- [ELTX.US](https://longbridge.com/en/quote/ELTX.US.md)
- [CLPT.US](https://longbridge.com/en/quote/CLPT.US.md)
- [SDEV.US](https://longbridge.com/en/quote/SDEV.US.md)
- [CODX.US](https://longbridge.com/en/quote/CODX.US.md)
- [CRVO.US](https://longbridge.com/en/quote/CRVO.US.md)
- [IMCC.US](https://longbridge.com/en/quote/IMCC.US.md)
- [RENB.US](https://longbridge.com/en/quote/RENB.US.md)

## Related News & Research

- [uniQure Stock Looks Drastically Undervalued After Upbeat FDA Meeting](https://longbridge.com/en/news/290232181.md)
- [UniQure gets FDA green light to file for Huntington's gene therapy approval](https://longbridge.com/en/news/290043389.md)
- [uniQure director Madhavan Balachandran disposes of USD 278,500 in common shares](https://longbridge.com/en/news/290105874.md)
- [Aditxt says DRW Securities files initial beneficial ownership statement showing 126,772 shares](https://longbridge.com/en/news/290097214.md)
- [uniQure reports early seizure reductions in low-dose AMT-260 Phase I/IIa trial for refractory temporal lobe epilepsy](https://longbridge.com/en/news/290286530.md)